Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    plx7486
Show Display Options
Rank Status Study
1 Recruiting Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors
Conditions: Solid Tumor;   Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations;   Tenosynovial Giant Cell Tumor
Intervention: Drug: PLX7486 TsOH

Study has passed its completion date and status has not been verified in more than two years.